Cleven Injection 4000 Anti-Xa IU/0.4 ml contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used extensively for the prevention and treatment of thromboembolic disorders. It helps reduce the risk of blood clot formation in patients undergoing surgery, those with prolonged immobilization, or individuals with certain cardiovascular conditions. This dosage strength is commonly prescribed for prophylactic anticoagulation and selected therapeutic indications based on patient risk factors.

Cleven Injection provides predictable anticoagulant activity with a favorable safety profile, making it a preferred option in both hospital and supervised outpatient care.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition and Mechanism of Action

Enoxaparin Sodium 4000 Anti-Xa IU/0.4 ml

Enoxaparin Sodium works by enhancing the activity of antithrombin III, leading to selective inhibition of coagulation factor Xa and partial inhibition of thrombin (factor IIa). Its main pharmacological actions include:

• Prevention of fibrin clot formation

• Reduction of clot growth and recurrence

• Maintenance of smooth blood flow without significantly interfering with platelet function

This targeted mechanism allows effective anticoagulation with reduced monitoring requirements.

Indications

Cleven Injection 4000 Anti-Xa IU/0.4 ml is indicated for:

• Prevention of deep vein thrombosis in patients undergoing general or orthopedic surgery

• Prevention of venous thromboembolism in bedridden or immobilized medical patients

• Treatment of deep vein thrombosis with or without pulmonary embolism

• Management of unstable angina and non-ST elevation myocardial infarction

• Anticoagulation during hemodialysis

The prescribed dose depends on clinical evaluation, patient weight, and thrombotic risk.

Benefits of Cleven Injection

• Reliable and predictable anticoagulant effect

• Lower risk of heparin-induced thrombocytopenia compared to unfractionated heparin

• Reduced need for routine laboratory monitoring

• Convenient subcutaneous administration

• Well-established efficacy and safety profile

Dosage and Administration

• Dosage and duration should be determined by a healthcare professional

• Administered by subcutaneous injection, usually in the abdominal area

• Injection sites should be rotated to minimize local irritation

• Not intended for intramuscular administration

Patients should follow medical instructions strictly for safe and effective use.

Safety Information and Precautions

Possible Side Effects

Some patients may experience:

• Bleeding or bruising at the injection site

• Thrombocytopenia

• Anemia

• Elevated liver enzymes

• Local discomfort, pain, or redness

Any signs of unusual bleeding should be reported promptly.

Precautions

• Contraindicated in patients with active major bleeding

• Use with caution in patients with renal impairment or bleeding disorders

• Platelet count and renal function monitoring may be recommended

• Inform your physician about all medications being taken

• Use during pregnancy or breastfeeding only if clearly prescribed

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Conditions

• Store as per label instructions

• Protect from light

• Do not freeze

• Keep out of reach of children

Conclusion

Cleven Injection 4000 Anti-Xa IU/0.4 ml (Enoxaparin Sodium) is a dependable anticoagulant used for the prevention and treatment of thromboembolic conditions. Its predictable action, ease of use, and strong clinical track record make it an essential choice in modern anticoagulation therapy under proper medical supervision.